Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Infectious Diseases Point-of-Care Diagnostic Market: By Component Type, By Technology, By Disease By End User and Geograpy
Infectious Disease Point of Care Diagnostics Market size was valued at US$ 3,547.8 million in 2023 and is expected to grow at a significant CAGR of 9.2% from 2024 - 2030. The global market provides a detailed overview of the global market and that can be segmented by components, by technique, by disease, and end-user. By components, The global market has been segmented into Instruments, Reagents and Kits, Software and Services. The instruments segment is likely to be the largest and fastest-growing segment in terms of type. Based on technique, the global market is segmented into Lateral flow immunoassay, Agglutination test, Molecular Diagnostics, and others. Among these, the lateral flow immunoassay segment is expected to have the fastest-growing market during the forecast period 2024-2030. By disease, the global market is segmented into HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others.
The respiratory tract infections segment accounts for the largest share in 2021. Hospital acquired infections is the second-largest share during the forecast period 2021-2028. Based on the end-user, the market has been segregated into Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others. The Hospitals and clinics segment is expected to dominate other segments in the global infectious disease point of care diagnostics market. The home care segment is expected to witness the highest CAGR during the forecast period according to precision business insights.
Study Period
2025-2031Base Year
2024CAGR
9.2%Largest Market
Asia-PacificFastest Growing Market
North-America
The key driving forces for the point-of-care infectious disease diagnostics market is to increase in the prevalence of infectious diseases such as HBV, HCV, HAIs, RTI, and others coupled with launch of advanced diagnostic test kits by the market players across the globe. Moreover, outbreak of COVID-19 drastically increased the revenue in 2020 and 2021.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2023 |
US$ 3,547.8 million |
Market CAGR |
9.2% |
By Component Type |
|
By Technology |
|
By Disease type |
|
By End User |
|
Download Free Sample Report
The global infectious diseases Point-of-Care (POC) diagnostic market size was valued at US$ 3,547.8 million in 2023 and is projected to grow at a CAGR of 9.2% from 2024 to 2030.
The major players in the global infectious disease point of care diagnostics market are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson, and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Quidel Corporation (U.S.)
North-America is the fastest-growing region for Infectious Diseases Point-of-Care (POC) Diagnostic Market
1. Executive Summary |
2. Global Infectious Disease Point of Care Diagnostics Market Introduction |
2.1. Global Infectious Disease Point of Care Diagnostics Market Taxonomy |
2.2. Global Infectious Disease Point of Care Diagnostics Market Definitions |
2.2.1. By Components |
2.2.2. By Technology |
2.2.3. By Disease Type |
2.2.4. By End User |
2.2.5. By Region |
3. Global Infectious Disease Point of Care Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Infectious Disease Point of Care Diagnostics Market Dynamic Factors - Impact Analysis |
3.6. Global Infectious Disease Point of Care Diagnostics Market Competition Landscape |
3.7. Epidemiology |
4. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Infectious Disease Point of Care Diagnostics Market, By Components, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Instruments |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Reagents and Kits |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Software and Services |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Infectious Disease Point of Care Diagnostics Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Lateral Flow Immunoassay |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Agglutination Test |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Molecular Diagnostics |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Infectious Disease Point of Care Diagnostics Market, Disease Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. HIV |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Hospital Acquired Infections |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. HBV |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Respiratory Tract Infections |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5. HPV |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6. HCV |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Tuberculosis |
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
7.8. COVID-19 |
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.8.3. Market Opportunity Analysis |
7.9. Others |
7.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.9.3. Market Opportunity Analysis |
8. Global Infectious Disease Point of Care Diagnostics Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Home Care |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Hospitals and Clinics |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Diagnostic Laboratories |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Academic and Research Institutes |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Others |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, By Technology, Disease Type, By End User, and Region, 2024 - 2030 |
10. North America Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Instruments |
10.1.2. Reagents and Kits |
10.1.3. Software and Services |
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Lateral Flow Immunoassay |
10.2.2. Agglutination Test |
10.2.3. Molecular Diagnostics |
10.2.4. others |
10.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. HIV |
10.3.2. Hospital Acquired Infections |
10.3.3. HBV |
10.3.4. Respiratory Tract Infections |
10.3.5. HPV |
10.3.6. HCV |
10.3.7. Tuberculosis |
10.3.8. COVID-19 |
10.3.9. Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Home Care |
10.4.2. Hospitals and Clinics |
10.4.3. Diagnostic Laboratories |
10.4.4. Academic and Research Institutes |
10.4.5. Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2024 - 2030 |
10.7. North America Infectious Disease Point of Care Diagnostics Market Dynamics Trends |
11. Europe Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Instruments |
11.1.2. Reagents and Kits |
11.1.3. Software and Services |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Lateral Flow Immunoassay |
11.2.2. Agglutination Test |
11.2.3. Molecular Diagnostics |
11.2.4. others |
11.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. HIV |
11.3.2. Hospital Acquired Infections |
11.3.3. HBV |
11.3.4. Respiratory Tract Infections |
11.3.5. HPV |
11.3.6. HCV |
11.3.7. Tuberculosis |
11.3.8. COVID-19 |
11.3.9. Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Home Care |
11.4.2. Hospitals and Clinics |
11.4.3. Diagnostic Laboratories |
11.4.4. Academic and Research Institutes |
11.4.5. Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Rest of Europe |
11.6. Europe Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2024 - 2030 |
11.7. Europe Infectious Disease Point of Care Diagnostics Market Dynamics Trends |
12. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Instruments |
12.1.2. Reagents and Kits |
12.1.3. Software and Services |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Lateral Flow Immunoassay |
12.2.2. Agglutination Test |
12.2.3. Molecular Diagnostics |
12.2.4. others |
12.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. HIV |
12.3.2. Hospital Acquired Infections |
12.3.3. HBV |
12.3.4. Respiratory Tract Infections |
12.3.5. HPV |
12.3.6. HCV |
12.3.7. Tuberculosis |
12.3.8. COVID-19 |
12.3.9. Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Home Care |
12.4.2. Hospitals and Clinics |
12.4.3. Diagnostic Laboratories |
12.4.4. Academic and Research Institutes |
12.4.5. Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2024 - 2030 |
12.7. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Dynamics Trends |
13. Latin America Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Instruments |
13.1.2. Reagents and Kits |
13.1.3. Software and Services |
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Lateral Flow Immunoassay |
13.2.2. Agglutination Test |
13.2.3. Molecular Diagnostics |
13.2.4. others |
13.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. HIV |
13.3.2. Hospital Acquired Infections |
13.3.3. HBV |
13.3.4. Respiratory Tract Infections |
13.3.5. HPV |
13.3.6. HCV |
13.3.7. Tuberculosis |
13.3.8. COVID-19 |
13.3.9. Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Home Care |
13.4.2. Hospitals and Clinics |
13.4.3. Diagnostic Laboratories |
13.4.4. Academic and Research Institutes |
13.4.5. Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2024 - 2030 |
13.7. Latin America Infectious Disease Point of Care Diagnostics Market Dynamics Trends |
14. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Instruments |
14.1.2. Reagents and Kits |
14.1.3. Software and Services |
14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Lateral Flow Immunoassay |
14.2.2. Agglutination Test |
14.2.3. Molecular Diagnostics |
14.2.4. others |
14.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. HIV |
14.3.2. Hospital Acquired Infections |
14.3.3. HBV |
14.3.4. Respiratory Tract Infections |
14.3.5. HPV |
14.3.6. HCV |
14.3.7. Tuberculosis |
14.3.8. COVID-19 |
14.3.9. Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Home Care |
14.4.2. Hospitals and Clinics |
14.4.3. Diagnostic Laboratories |
14.4.4. Academic and Research Institutes |
14.4.5. Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2024 - 2030 |
14.7. MEA Infectious Disease Point of Care Diagnostics Market Dynamics Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Cepheid Inc. (Danaher Corporation) (U.S.) |
15.2.2. Abbott Laboratories, Inc. (U.S.) |
15.2.3. Hoffmann La Roche Limited (Switzerland) |
15.2.4. Beckman Coulter, Inc. (U.S.) |
15.2.5. Siemens AG (Germany) |
15.2.6. Johnson & Johnson Services, Inc. (U.S.) |
15.2.7. Instrumentation Laboratory (U.S.) |
15.2.8. Becton, Dickinson and Company (U.S.) |
15.2.9. Alere Inc. (U.S.) |
15.2.10. Nova Biomedical (U.S.) |
15.2.11. Thermo Fisher Scientific Inc. (U.S.) |
15.2.12. Quidel Corporation (U.S.) |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players